Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder
International Journal of Mental Health and Addiction – March 07, 2024
Source: OpenAlex
Summary
A compelling finding in clinical psychology reveals that Psilocybin Therapy's unique antidepressant effects for Major depressive disorder are strongly linked to acute psychological experiences. In a phase 2 trial over a 6-week period, compared to Escitalopram, profound "mystical experience" and "ego dissolution" uniquely mediate Psilocybin's positive impact. This work, part of ongoing Psychedelics and Drug Studies in psychiatry, suggests that these intense subjective states, perhaps guided by a psychotherapist, are crucial. Higher reported levels of such experiences correlate with greater improvement, offering insights into novel antidepressant approaches.
Abstract
Abstract The mechanisms by which Psilocybin Therapy (PT) improves depression remain an important object of study, with scientists actively exploring acute psychological experiences and neurobiological processes as candidates. In a phase 2, double-blind, randomized, active comparator controlled trial involving patients with moderate-to-severe major depressive disorder, we investigated whether acute psychological experiences could meaningfully account for the unique efficacy of PT versus Escitalopram Treatment over a core 6-week trial period. An exploratory-factor-analysis-derived single-factor of depression was used as the outcome. Among a comprehensive set of acute experiences related to psilocybin, so-called “mystical experience” and “ego dissolution” were unique in mediating the effect of treatment condition on depressive response with high specificity. Higher reported levels of mystical experience, emotional breakthrough, and intense responses to music-listening were furthermore associated with greater antidepressant response. These results provide qualified support for the causal mechanistic role of acute psychological experiences in the treatment of depression via PT.